Sort
30,917 grants matching “tumor microenvironment”
Metabolic Control of Innate and Adaptive Immunity in Breast Cancer
$433,609Guangyong Peng · Washington University · R01 · FY2023 · CA
Develop RAMAN imaging to visualize metabolism in cell lines and tissue
$433,587Mioara Larion · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer
$433,516Cesar M Castro · Massachusetts General Hospital · R01 · FY2023 · CA
Mechano-regulation of bone metastatic cancer: linking cell strain to cell function
$433,500Maureen E Lynch · University Of Massachusetts Amherst · · FY2016 · ENG
Study of Interleukin 33 as a new immunotherapy of lung cancer
$433,485Binfeng Lu · Hackensack University Medical Center · R01 · FY2023 · CA
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
$433,463Melissa L Fishel · Indiana University Indianapolis · R01 · FY2025 · CA
Epithelial cell complement production in the pathogenesis of chronic rhinosinusitis
$433,451Carl Atkinson · University Of Florida · R01 · FY2021 · AI
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$433,439Melody A Swartz · University Of Chicago · R01 · FY2021 · CA
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers
$433,417Richard A. Cerione · Cornell University · R01 · FY2024 · CA
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
$433,375Ann Marie Pendergast · Duke University · R01 · FY2021 · CA
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
$433,366Walter J Storkus · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$433,352Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$433,352Jorge Moscat · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · DK
Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for Glioblastoma
$433,323Andrew E Sloan · Case Western Reserve University · U01 · FY2021 · CA
Low-Power Stimulated Raman Time-Lapse Microscope for Tracking Dynamics and Fate of Lipid Droplets in Glioma Cells
$433,323Fake Lu · State University Of Ny,Binghamton · R15 · FY2020 · GM
Lung Cancer Vaccine
$433,293Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2024 · CA
Targeting a PHGDH metabolic vulnerability in melanoma
$433,256Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2024 · CA
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
$433,229Arvind P Pathak · Johns Hopkins University · R01 · FY2021 · CA
Pathogenic reciprocal interplay between cyst epithelium and myofibroblasts in polycystic kidney disease
$433,227Reena Rao · University Of Kansas Medical Center · R01 · FY2025 · DK
Role of the microenvironment in ovarian cancer metastasis
$433,181Katherine Cynthia Fuh · Washington University · R01 · FY2020 · CA
Role of histotripsy synergized CD40 signaling in the re-engineering of cold tumors
$433,173Ashish Ranjan · Oklahoma State University Stillwater · R01 · FY2022 · CA
Lipid-Rich Macrophages at the Tumor-Adipose Interface: A New Target for Locally-Invasive Prostate Cancer Therapy
$433,157Simon W. Hayward · Endeavor Health Clinical Operations · R21 · FY2024 · CA
Neuroimmunomodulation within the eye
$433,125Andrew W Taylor · Schepens Eye Research Institute · R01 · FY2009 · EY
Biophysical and Biochemical Effects of the ECM on Breast Epithelial Cells
$433,069Celeste M Nelson · Princeton University · R01 · FY2015 · CA
Lung Cancer Vaccine
$433,048Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · U54 · FY2025 · CA